Navigation Links
CAPS Provides Input on Draft Sterile Compounding Legislation
Date:5/3/2013

BETHLEHEM, Pa., May 3, 2013 /PRNewswire/ -- Supporting consistent federal oversight of sterile compounding in the United States, Central Admixture Pharmacy Services, Inc. (CAPS®), a B. Braun company, submitted its comments today to the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) regarding the committee's draft legislation on sterile compounding.

"We strongly believe that consistency will be the key," said Mike Koch , CAPS Vice President, Marketing and Support Services. "To help ensure both patient safety and confidence in the nation's drug supply, it's important to hold all compounded sterile preparations made in the U.S. to a consistent set of quality standards, while avoiding potentially dangerous loopholes."

CAPS delivers compounded sterile preparations daily, both locally and nationwide, from 25 locations. Included in the comments submitted to the Committee was support for the newly proposed "Compounding Manufacturer" category. CAPS looks forward to further engaging in the dialogue on this important patient safety legislation.

About CAPS

CAPS®, the nation's largest network of outsourcing admixture pharmacies, was pioneered in 1991 to deliver high-quality admixture services and solutions to a dynamic and challenging pharmacy environment. State-licensed and FDA-registered, CAPS pharmacies operate 365 days a year to dispense labeled, patient-specific and anticipatory IV prescriptions. To learn more about CAPS, visit www.capspharmacy.com.

About B. Braun

B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 46,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.


'/>"/>
SOURCE Central Admixture Pharmacy Services, Inc. (CAPS®), a B. Braun company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals Provides Efinconazole Update
2. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
3. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
4. Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidanc
5. DietBrandReviews.com Provides a Comprehensive Review of the Dukan Diet
6. Hill-Rom Reports Fiscal Second Quarter Adjusted Earnings Per Share In Line With Expectations; Provides Third Quarter And Updated Full-Year Financial Outlook
7. Medical Alarm Concepts Files Information Statement and Provides Update on Corporate Activity
8. Hand-Held Device Provides Lab-Quality Troponin Test Results in 15 Minutes to Identify Patients Suspected of Heart Attack
9. Accuray Provides Clarification on Recently Initiated Voluntary Recalls
10. Centers for Specialty Care Group Provides On-Site Dialysis at Many of Its NYC Rehab Centers
11. DocuTrac, Inc. Provides Cloud Hosted Solution for Behavioral Health Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
Breaking Medicine News(10 mins):